Biomedical Innovation Linker & DevTank: Identifying Demand for Innovation

MGDII HEALTH INNOVATION, COMMERCIALIZATION & ENTREPRENEURSHIP PROGRAMMING exists at the intersection of innovative research and entrepreneurial thinking, and supports researchers, clinicians and trainees interested in exploring health innovation opportunities and developing new venturesForward this to anyone interested in health innovation, commercialization or entrepreneurship! 

Contact Sarrah Lal (Assistant Professor and Senior Manager, MGDII) with any questions.Subscribe to our e-newsletter here.

REGISTER TODAY

On February 7 from 6-8:00 PM, the Faculties of Health Sciences, Engineering and Business are hosting the Biomedical Innovation Linker. This event is intended to bring together clinicians, researchers, engineers, industry professionals and students interested, or engaged, in biomedical innovation. The discussion will be focused on how collaboration between the disciplines is critical to biomedical venture development. The evening will include opportunities for learning, collaborative discussions between disciplines, and network creation!
 
SPEAKERS INCLUDE..
Serge Aguirre (Chief Executive Officer, Epineuron)
Richard Fanson (Co-founder and Chief Science Officer, Intellijoint Surgical)
Fran Lasowski (Co-Founder and Chief Executive Officer, 20/20 OptimEyes)
Paul Weber (Co-Founder and Chief Business Officer, Perimeter Medical)

AGENDA
5:30 – 6:00 | SIGN-IN + REFRESHMENTS
6:00 – 6:15 | OPENING REMARKS
  6:15 – 7:00 | PANEL DISCUSSION
7:00 – 7:45 | DISCUSSION TABLES
7:45 – 9:00 | OPEN NETWORKING


For a full event overview please see here.

COMMERCIALIZATION: 
ECOSYSTEMS - FACILITATING VS HINDERING HEALTH INNOVATION
JANUARY 31 | ONLINE | 5:00 - 6:00 PM | REGISTER

COMMERCIALIZATION:
BUDGETING FOR HEALTH INNOVATION START-UPS
FEBRUARY 6 | ONLINE | 5:00 - 6:00 PM | REGISTER

CREATING DEMAND FOR INNOVATION:
A MULTI-PERSPECTIVE ANALYSIS

TUES JAN 29
HSC 4H30C | 4:00 - 6:00 PM | REGISTER

Join us as we discuss "Promising New Cancer Treatments Come With Questions About Cost" a podcast regarding the question of cost versus effectiveness for upcoming therapies, using CAR-T cell therapy as a case example. The discussion will be followed by a conversation about analyzing and tying together multiple stakeholder perspectives.

2b74888a-705b-4773-b3af-75e3dbe2064f.png